deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT06675344

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)

A Randomized, Double-blind, Clinical Trial of the Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)

Sponsor: Robyn T. Domsic, MD, MPH

Conditions Systemic Sclerosis (SSc)
Interventions Apollo Neuro Device Sham device
Updated 3 times since 2024 Last updated: Jan 7, 2026 Started: Jan 6, 2025 Primary completion: Mar 1, 2028 Completion: Sep 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06675344, this NA trial focuses on Systemic Sclerosis (SSc) and remains actively recruiting participants. Sponsored by Robyn T. Domsic, MD, MPH, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2024 – ~Mar 2025 · 3 months · monthly snapshotNot Yet Recruiting~Mar 2025 – ~Feb 2026 · 11 months · monthly snapshotRecruiting~Feb 2026 – present · 7 months · monthly snapshotRecruiting

Change History

3 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting NA

  2. Mar 2025 — Feb 2026 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  3. Dec 2024 — Mar 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Robyn T. Domsic, MD, MPH
  • United States Department of Defense
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations